These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11164803)

  • 41. Axonal degeneration of nigra-striatum dopaminergic neurons induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Li LH; Qin HZ; Wang JL; Wang J; Wang XL; Gao GD
    J Int Med Res; 2009; 37(2):455-63. PubMed ID: 19383240
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
    Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
    Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dopaminergic and behavioral correlates of progressive lesioning of the nigrostriatal pathway with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Goldberg NR; Haack AK; Lim NS; Janson OK; Meshul CK
    Neuroscience; 2011 Apr; 180():256-71. PubMed ID: 21335067
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vigilance states in a parkinsonian model, the MPTP mouse.
    Monaca C; Laloux C; Jacquesson JM; Gelé P; Maréchal X; Bordet R; Destée A; Derambure P
    Eur J Neurosci; 2004 Nov; 20(9):2474-8. PubMed ID: 15525288
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of organotypic ventral mesencephalic cultures from embryonic mice and protection against MPP toxicity by GDNF.
    Jakobsen B; Gramsbergen JB; Møller Dall A; Rosenblad C; Zimmer J
    Eur J Neurosci; 2005 Jun; 21(11):2939-48. PubMed ID: 15978005
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diethyldithiocarbamate causes nigral cell loss and dopamine depletion with nontoxic doses of MPTP.
    Walters TL; Irwin I; Delfani K; Langston JW; Janson AM
    Exp Neurol; 1999 Mar; 156(1):62-70. PubMed ID: 10192777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FGF-2 deficiency does not alter vulnerability of the dopaminergic nigrostriatal system towards MPTP intoxication in mice.
    Zechel S; Jarosik J; Kiprianova I; Schober A; Unsicker K; von Bohlen und Halbach O
    Eur J Neurosci; 2006 Mar; 23(6):1671-5. PubMed ID: 16553632
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Calretinin-containing axons and neurons are resistant to an intrastriatal 6-hydroxydopamine lesion.
    Tsuboi K; Kimber TA; Shults CW
    Brain Res; 2000 Jun; 866(1-2):55-64. PubMed ID: 10825480
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Degeneration of dopaminergic neurons in the substantia nigra of zitter mutant rat and protection by chronic intake of Vitamin E.
    Ueda S; Sakakibara S; Nakadate K; Noda T; Shinoda M; Joyce JN
    Neurosci Lett; 2005 Jun; 380(3):252-6. PubMed ID: 15862896
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence for a dopaminergic innervation of the pedunculopontine nucleus in monkeys, and its drastic reduction after MPTP intoxication.
    Rolland AS; Tandé D; Herrero MT; Luquin MR; Vazquez-Claverie M; Karachi C; Hirsch EC; François C
    J Neurochem; 2009 Aug; 110(4):1321-9. PubMed ID: 19527435
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exploring the neuroprotective effects of modafinil in a marmoset Parkinson model with immunohistochemistry, magnetic resonance imaging and spectroscopy.
    van Vliet SA; Blezer EL; Jongsma MJ; Vanwersch RA; Olivier B; Philippens IH
    Brain Res; 2008 Jan; 1189():219-28. PubMed ID: 18076869
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
    Shin JY; Park HJ; Ahn YH; Lee PH
    J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Promethazine protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.
    Cleren C; Starkov AA; Calingasan NY; Lorenzo BJ; Chen J; Beal MF
    Neurobiol Dis; 2005 Dec; 20(3):701-8. PubMed ID: 16126396
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aucubin alleviates glial cell activation and preserves dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian mice.
    Zhu YL; Sun MF; Jia XB; Zhang PH; Xu YD; Zhou ZL; Xu ZH; Cui C; Chen X; Yang XS; Shen YQ
    Neuroreport; 2018 Sep; 29(13):1075-1083. PubMed ID: 29985188
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pramipexole attenuates the dopaminergic cell loss induced by intraventricular 6-hydroxydopamine.
    Vu TQ; Ling ZD; Ma SY; Robie HC; Tong CW; Chen EY; Lipton JW; Carvey PM
    J Neural Transm (Vienna); 2000; 107(2):159-76. PubMed ID: 10847557
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuroprotective effects of Polygonum multiflorum on nigrostriatal dopaminergic degeneration induced by paraquat and maneb in mice.
    Li X; Matsumoto K; Murakami Y; Tezuka Y; Wu Y; Kadota S
    Pharmacol Biochem Behav; 2005 Oct; 82(2):345-52. PubMed ID: 16214209
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo modulation of dopaminergic nigrostriatal pathways by cytisine derivatives: implications for Parkinson's Disease.
    Abin-Carriquiry JA; Costa G; Urbanavicius J; Cassels BK; Rebolledo-Fuentes M; Wonnacott S; Dajas F
    Eur J Pharmacol; 2008 Jul; 589(1-3):80-4. PubMed ID: 18589414
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism.
    Muñoz A; Rey P; Guerra MJ; Mendez-Alvarez E; Soto-Otero R; Labandeira-Garcia JL
    Neuropharmacology; 2006 Jul; 51(1):112-20. PubMed ID: 16678218
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of nicotine on 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced depression of striatal dopamine content and spontaneous locomotor activity in C57 black mice.
    Gao ZG; Cui WY; Zhang HT; Liu CG
    Pharmacol Res; 1998 Aug; 38(2):101-6. PubMed ID: 9721596
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson's disease.
    Chao YX; He BP; Tay SS
    J Neuroimmunol; 2009 Nov; 216(1-2):39-50. PubMed ID: 19819031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.